Bosh sahifaVX1 • ETR
add
Vertex Pharmaceuticals Inc
Yopilish kursi
424,55 €
Kunlik diapazon
420,15 € - 429,00 €
Yillik diapazon
353,40 € - 489,20 €
Bozor kapitalizatsiyasi
113,70 mlrd USD
Oʻrtacha hajm
168,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Benzinga
1 soat oldin
Vertex Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (21
Ratings)
0,19%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,77 mlrd | 11,61% |
Joriy xarajat | 371,80 mln | 40,94% |
Sof foyda | 1,05 mlrd | 0,98% |
Sof foyda marjasi | 37,71 | -9,55% |
Har bir ulushga tushum | 4,38 | 7,35% |
EBITDA | 1,18 mlrd | 4,56% |
Amaldagi soliq stavkasi | 14,60% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 6,52 mlrd | -45,30% |
Jami aktivlari | 22,24 mlrd | 2,37% |
Jami passivlari | 6,61 mlrd | 26,78% |
Umumiy kapital | 15,63 mlrd | — |
Tarqatilgan aksiyalar | 257,53 mln | — |
Narxi/balansdagi bahosi | 7,00 | — |
Aktivlardan daromad | 13,35% | — |
Kapitaldan daromad | 17,09% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,05 mlrd | 0,98% |
Operatsiyalardan naqd pul | 1,37 mlrd | 7,99% |
Sarmoyadan naqd pul | -348,00 mln | -195,67% |
Moliyadan naqd pul | -387,50 mln | -134,85% |
Naqd pulning sof oʻzgarishi | 657,10 mln | -31,78% |
Boʻsh pul | 1,09 mlrd | 18,41% |
Haqida
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
Tashkil etilgan
1989
Sayt
Xodimlar soni
5 400
